The past week has been one of desperate, drug-related if-onlys. First we had the tragic death of Liam Payne; then came the ...

Turning a weakness into a strength isn’t just a wise saying that makes for a good motivational poster or positive social ...

After initially sharing her stage 3 status in 2020, Lewis said she decided to go against having a doctor-recommended double ...

“But current early-stage drug development practices still primarily focus on drug testing in white populations of Northern European descent.” Under the provisions of the recently enacted Food ...

Nido Biosciences (Nido Bio), a clinical stage company developing precision medicines for debilitating neurological diseases, ...

Zoe Saldaña felt stuck in her career after acting in so many blockbuster Hollywood sequels. Then "Emilia Perez" arrived and ...

BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...

After a year of disappointing drug trial results, Sage Therapeutics Inc. is slashing its headcount and shaking up its ...

Phase 2 filing on track for Q1 2025 "The acceptance of our third U.S. IND is an important milestone for Aligos,” said ...

In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Perspective Therapeutics (CATX – Research Report), ...

Novo Nordisk on Monday reported the oral version of its drug semaglutide reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes by 14% in a large Phase III trial.

Drug development in oncology is historically challenging, exhibiting a very high attrition rate, with low rates of approval for novel treatments when compared to other therapeutic areas. At present, ...